Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 193-198

  Noto, Davide ^a   Cefalù, Angelo B ^a   Cannizzaro, Alessandra ^a   Minà, Mariangela ^a   Fayer, Francesca ^a   Valenti, Vincenza ^a   Barbagallo, Carlo M ^a   Tuttolomondo, Antonino ^b   Pinto, Antonio ^b   Sciumè, Carmelo ^a   Licata, Giuseppe ^b   Averna, Maurizio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

FHBL; Intestinal biopsy; Oral fat load; Triglyceride kinetics

Indexed keywords

APOLIPOPROTEIN B; GENOMIC DNA; LIPID; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; RETINOL PALMITATE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; ESOPHAGOGASTRODUODENOSCOPY; FAMILIAL HYPOBETALIPOPROTEINEMIA; FAT INTAKE; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; INTESTINE BIOPSY; LIPID ABSORPTION; LIPID STORAGE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PATHOGENESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEINS B; CARRIER PROTEINS; CHILD; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOBETALIPOPROTEINEMIA, FAMILIAL, APOLIPOPROTEIN B; INTESTINAL MUCOSA; INTRA-ABDOMINAL FAT; LIPID METABOLISM; MALE; MIDDLE AGED; MUTATION, MISSENSE; POSTPRANDIAL PERIOD; TRIGLYCERIDES; VITAMIN A;

EID: 68949210547     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.037     Document Type: Article

References (26)

1. Whitfield A.J., Barrett P.H., van Bockxmeer F.M., and Burnett J.R. Lipid disorders and mutations in the APOB gene. Clin Chem 50 10 (2004) 1725-1732
2. Schonfeld G., Lin X., and Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci 62 12 (2005) 1372-1378
3. Wetterau J.R., Aggerbeck L.P., Bouma M.E., et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258 5084 (1992) 999-1001
4. Leiper J.M., Bayliss J.D., Pease R.J., Brett D.J., Scott J., and Shoulders C.C. Microsomal triglyceride transfer protein, the abetalipoproteinemia gene product, mediates the secretion of apolipoprotein B-containing lipoproteins from heterologous cells. J Biol Chem 269 35 (1994) 21951-21954
5. Burnett J.R., Shan J., Miskie B.A., et al. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem 278 15 (2003) 13442-13452
6. Tarugi P., and Lonardo A. Heterozygous familial hypobetalipoproteinemia associated with fatty liver. Am J Gastroenterol 92 (1997) 1400-1402
7. Schonfeld G., Patterson B.W., Yablonskiy D.A., et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res 44 (2003) 470-478
8. Chan L., Chang B.H., Nakamuta M., Li W.H., and Smith L.C. Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta 1345 (1997) 11-26
9. Tarugi P., Averna M., Di Leo E., et al. Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Atherosclerosis 195 (2007) e19-27
10. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11 10 (1999) 1185-1194
11. Joseph A.E., and Saverymuttu S.H. Ultrasound in the assessment of diffuse parenchymal liver disease. Clin Radiol 44 (1991) 219-221
12. Tarugi P., Lonardo A., Gabelli C., et al. Phenotypic expression of familial hypobetalipoproteinemia in three kindred with mutations of apolipoprotein B gene. J Lipid Res 42 10 (2001) 1552-1561
13. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
14. Noto D., Rizzo M., Barbagallo C.M., et al. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low density lipoprotein receptor binding affinity. Metabolism 55 10 (2006) 1308-1316
15. Iacono G., Carroccio A., Montalto G., Cavataio F., Balsamo F., and Notarbartolo A. Steatocrit test after a standard fatty meal: a new simple and sensitive test to detect malabsorption. J Pediatr Gastroenterol Nutr 13 (1991) 161-167
16. Srivastava R.A., Srivastava N., Averna M., Cefalu A.B., and Schonfeld G. Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene. J Lipid Res 40 (1999) 901-912
17. Chen Z., Fitzgerald R.L., Averna M.R., and Schonfeld G. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. J Biol Chem 275 (2000) 32807-32815
18. Whitfield A.J., Barrett P.H.R., Robertson K., Havlat M.F., van Bockxmeer F.M., and Burnett J.R. Liver dysfunction and steatosis in familial hypobetalipoproteinemia. Clin Chem 51 (2005) 266-269
19. Segrest J.P., Jones M.K., and Dashti N. N-terminal domain of apolipoprotein B has structural homology to lipovitellin and microsomal triglyceride transfer protein: a "lipid pocket" model for self-assembly of apob-containing lipoprotein particles. J Lipid Res 40 8 (1999) 1401-1416
20. Burnett J.R., Zhong S., Jiang Z.G., et al. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia. J Biol Chem 282 33 (2007) 24270-24283
21. Hooper A.J., Robertson K., Barrett P.H., Parhofer K.G., van Bockxmeer F.M., and Burnett J.R. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia. J Clin Endocrinol Metab 92 4 (2007) 1474-1478
22. Berr F. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans. J Lipid Res 33 (1992) 915-930
23. Burnett J.R., Proos A.L., Koutts J., and Burnett L. Familial hypobetalipoproteinaemia: a rare presentation to the lipid clinic. Med J Aust 159 4 (1993) 272-274
24. Yue P., Isley W.L., Harris W.S., Rosipal S., Akin C.D., and Schonfeld G. Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in HBL. Atherosclerosis 178 1 (2005) 107-113
25. Ohashi K., Ishibashi S., Yamamoto M., et al. A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus. Arterioscler Thromb Vasc Biol 18 (1998) 1330-1334
26. Jones B., Jones E.L., Bonney S.A., et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34 1 (2003) 29-31